FUSION BIOVENTURE Trademark

Trademark Overview


On Monday, February 21, 2022, a trademark application was filed for FUSION BIOVENTURE with the United States Patent and Trademark Office. The USPTO has given the FUSION BIOVENTURE trademark a serial number of 97276885. The federal status of this trademark filing is REGISTERED as of Tuesday, March 28, 2023. This trademark is owned by Fosun Pharma USA Inc.. The FUSION BIOVENTURE trademark is filed in the Insurance & Financial Services and Computer & Software Services & Scientific Services categories with the following description:

Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies

Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Consulting services in the field of pharmacogenetics; Pharmaceutical research and development; Scientific research and development; Vaccine research and development
fusion bioventure

General Information


Serial Number97276885
Word MarkFUSION BIOVENTURE
Filing DateMonday, February 21, 2022
Status700 - REGISTERED
Status DateTuesday, March 28, 2023
Registration Number7011432
Registration DateTuesday, March 28, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2023

Trademark Statements


Goods and ServicesProviding venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies
Disclaimer with Predetermined Text"BIOVENTURE"
Goods and ServicesConsulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Consulting services in the field of pharmacogenetics; Pharmaceutical research and development; Scientific research and development; Vaccine research and development

Classification Information


International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, February 24, 2022
Primary Code036
First Use Anywhere DateMonday, August 31, 2020
First Use In Commerce DateMonday, August 31, 2020

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 24, 2022
Primary Code042
First Use Anywhere DateMonday, August 31, 2020
First Use In Commerce DateMonday, August 31, 2020

Trademark Owner History


Party NameFosun Pharma USA Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Party NameFosun Pharma USA Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Party NameFosun Pharma USA Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events


Event DateEvent Description
Tuesday, March 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 28, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, January 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2023PUBLISHED FOR OPPOSITION
Wednesday, December 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 5, 2022ASSIGNED TO EXAMINER
Thursday, February 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 24, 2022NEW APPLICATION ENTERED